Retrospective Collection of Safety & Performance Data

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04520087` - Clinical and Radiographic Assessment After Surgical Treatment of Anterior Shoulder Dislocation	N/A
Active, not recruiting	`NCT03103295` - 3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects	Phase 1/Phase 2
Recruiting	`NCT06269354` - Multi-center Study on Comprehensive Diagnosis and Treatment of Lower Limb Bone Defect Based on Three-dimensional Printing Technology
Recruiting	`NCT04645186` - Calcium Phosphate Cement as Bone Void Filler

See also

Status

Clinical Trial

Phase

Recruiting

NCT04520087 - Clinical and Radiographic Assessment After Surgical Treatment of Anterior Shoulder Dislocation

N/A

Active, not recruiting

NCT03103295 - 3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects

Phase 1/Phase 2

Recruiting

NCT06269354 - Multi-center Study on Comprehensive Diagnosis and Treatment of Lower Limb Bone Defect Based on Three-dimensional Printing Technology

Recruiting

NCT04645186 - Calcium Phosphate Cement as Bone Void Filler

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04644536
Study type	Observational
Source	Bioceramed
Contact	A.C. Manjua
Phone	00351 210 966 988
Email	clinicalresearch@bioceramed.com
Status	Recruiting
Phase
Start date	November 25, 2020
Completion date	December 2023

Retrospective Collection of Safety and Performance Data

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms